Search Contact
News
17/10/2018
The AB-Biotics Personalized Medicine Platform (NEUROFARMAGEN) Increases Psychiatric Treatment Efficacy by 67%
As part of the European College of Neuropsychopharmacology (ECNP), the biotechnology company AB-Biotics presented a study showing that patients with major depressive disorder following therapies based on pharmacogenetics improve their response to medication.
Read More
24/09/2018
UIC Barcelona and AB Biotics join forces to carry out investigations in the field of probiotics
The leading biotechnology company AB Biotics and the International University of Barcelona (UIC Barcelona) have signed a collaboration agreement for the next three years with the aim of developing investigation projects that contribute to improving people’s health and wellness. Specifically, both entities will work jointly in the development of the Polyphosphate and...
Read More
13/08/2018
AB-Biotics completes its Board of Directors by naming two independent members
By incorporating Josep Maria Echarri, Managing Director of Inveready Asset Management, and Joan Ramón Ramos, a renowned economist with a long trajectory in the world of business consultancy, AB Biotics completes the new structure of its Board of Directors and corporate government. The Board also counts with Sergi Audivert and Miquel Àngel...
Read More
05/07/2018
AB Biotics renews its Board of Directors to begin a new cycle
- Yesterday’s Annual General Meeting of Shareholders named the members of the new Board of Directors - The founding partners are now joined by Luís Sánchez-Lafuente and four board members from Kaneka Corporation, all of whom are dominical - The two founding partners, Sergi Audivert and Miquel Àngel Bonachera, together with Luis...
Read More
07/06/2017
Meet us at “International meeting on personalized medicine in psychiatry” in Pisa
Meet us at “International meeting on personalized medicine in psychiatry” in Pisa, June 8th at 10:30h, and discuss with our geneticist Dr. Miquel Tuson, about the "Lessons from the AB-GEN  randomized multicentric trial on practical pharmacogenetics in maj
Read More
02/06/2017
Meet us at Probiota Americas at Friday, June 9th at 11am, and discuss with Dr. Espadaler about ‘Probiotics in Gingivitis Management, a new clinical trial’.
Meet us at Probiota Americas at Friday, June 9th at 11am, and discuss with Dr. Espadaler about ‘Probiotics in Gingivitis Management, a new clinical trial’.
Read More
02/06/2017
Join us at Probiota Americas at Thursday, June 8th at 12.30 pm, and discuss with Dr. Espadaler about ‘New clinical evidence and market experiences about probiotics for cardiovascular Health’.
Join us at Probiota Americas at Thursday, June 8th at 12.30 pm, and discuss with Dr. Espadaler about ‘New clinical evidence and market experiences about probiotics for cardiovascular Health’.
Read More
30/05/2017
AB-Biotics finalizes a study that supports the probiotic AB-Kolicare® to reduce crying caused by colic of the infant
AB-Biotics shows new and promising clinical evidence on the use of its probiotic AB-Kolicare® in the treatment of childhood colic. The disorder accounts for between 10% and 20% of pediatric visits in the first 4 months of a baby's life.
Read More
30/05/2017
The AB-Biotics team at Vitafoods Europe, 9-11 May 2017, Palexpo (Geneva)
The AB-Biotics team at Vitafoods Europe, 9-11 May 2017, Palexpo (Geneva)
Read More